Vanda Pharmaceuticals
VNDA
#7059
Rank
HK$4.00 B
Marketcap
HK$67.80
Share price
0.58%
Change (1 day)
71.75%
Change (1 year)

EPS for Vanda Pharmaceuticals (VNDA)

EPS in 2025 (TTM): -HK$11.08

According to Vanda Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$11.13. In 2024 the company made an earnings per share (EPS) of -HK$2.51 a decrease over its 2023 EPS that were of HK$0.41.

EPS history for Vanda Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$11.08341.73%
2024-HK$2.51-710.9%
2023HK$0.41-56.35%
2022HK$0.94-80%
2021HK$4.70
2019HK$17.01334%
2018HK$3.92-247.06%
2017-HK$2.66-19.05%
2016-HK$3.29-55.32%
2015-HK$7.37-347.37%
2014HK$2.98-156.72%
2013-HK$5.25-31.63%
2012-HK$7.68

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.29-884.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.69-618.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.66-195.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$180.42-1,721.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$57.27-614.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$23.28-309.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-HK$34.41 209.15%๐Ÿ‡บ๐Ÿ‡ธ USA